Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Aug;48(4):518-25.
doi: 10.1007/s12275-010-9388-2. Epub 2010 Aug 20.

Heterogeneous virulence potential and high antibiotic resistance of Pseudomonas aeruginosa strains isolated from Korean pneumonia patients

Affiliations

Heterogeneous virulence potential and high antibiotic resistance of Pseudomonas aeruginosa strains isolated from Korean pneumonia patients

Mi Young Yoon et al. J Microbiol. 2010 Aug.

Abstract

Pseudomonas aeruginosa is an opportunistic human pathogen of clinical importance that causes airway infections in immunocompromised patients. Here, we report the virulence-associated characteristics of strains of P. aeruginosa, isolated from the sputa of 25 Korean pneumonia patients. A high degree of genomic plasticity was observed by random amplified polymorphic DNA genotype analysis, suggesting that the infections were caused by strains with diverse genomic backgrounds. Biofilm formation of each isolate was heterogeneous in terms of their relative motilities. In addition, 48% of isolates were defective in the production of 3-oxo-C(12)-HSL (PAI-1), a quorum sensing signal molecule. In these strains, PAI-1-dependent elastase production was correspondingly decreased, suggesting that a large number of strains were presumed to be quorum sensing deficient. Multidrug resistance (MDR) was seen in 56% of the isolates tested, and 44% of the MDR strains were resistant to five or more antibiotics. Taken together, our results provide additional insights into the virulence traits of P. aeruginosa clinical isolates, which will aid in treating P. aeruginosa infections in pneumonia patients.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Microbiology (Reading). 1999 Jun;145 ( Pt 6):1349-1357 - PubMed
    1. J Immunol. 2005 Dec 1;175(11):7512-8 - PubMed
    1. Antimicrob Agents Chemother. 1995 Feb;39(2):489-95 - PubMed
    1. FEMS Microbiol Lett. 2009 Dec;301(2):210-7 - PubMed
    1. Mol Microbiol. 1998 Oct;30(2):295-304 - PubMed

Publication types

MeSH terms

LinkOut - more resources